Related by context. All words. (Click for frequent words.) 72 NS5B polymerase 69 cortisol synthesis 69 folate analogue metabolic 69 oral dihydropyrimidine dehydrogenase DPD 69 selective inhibitor 68 cyclin dependent kinase CDK 68 novel topoisomerase 67 CYP#A# CYP#D# 67 highly selective inhibitor 67 inflammatory PDE 66 Janus kinase 66 selective antagonist 66 reversible inhibitor 66 targeting CD# 66 ENMD # 66 alpha folate receptor 66 multi kinase inhibitor 66 oral Factor Xa 66 signal transduction inhibitor 65 anti miRs antisense oligonucleotide 65 CYT# potent vascular disrupting 65 polymerase inhibitor 65 CYP#A# isoenzyme 65 certain protein tyrosine 65 5 HT6 receptor 65 oral JAK1 65 HCV RNA polymerase 65 agonistic human 65 oral isoform selective HDAC 65 ADP receptor antagonist 65 pan HDAC inhibitor 64 oral prodrug 64 Aurora kinase 64 cytidine nucleoside analog 64 selective adhesion molecule 64 NS5b 64 DGAT 64 sodium glucose cotransporter 64 triciribine phosphate monohydrate 64 selective kinase inhibitor 64 small molecule inhibitor 64 Lenocta TM sodium stibogluconate 64 developing Bicifadine serotonin 64 5 HT2A serotonin 64 cMet 64 orally administered inhibitor 64 MEK1 64 Mg Usa 64 investigational humanized monoclonal antibody 64 AAG geldanamycin analog 64 Janus Kinase 64 pan Bcl 2 64 PNP inhibitor 64 non nucleoside inhibitor 64 small molecule tyrosine 63 MT# MEDI 63 related apoptosis inducing 63 HCV NS5B polymerase 63 induces apoptosis 63 liposomal formulation 63 cyclin dependent kinase inhibitor 63 VEGFR2 inhibitor 63 pan histone deacetylase 63 selective orally bioavailable 63 vesicular monoamine transporter 63 selective inhibition 63 irreversible inhibitor 63 DNA methyltransferase inhibitors 63 sunitinib Sutent ® 63 IAP inhibitor 63 Factor Receptor 63 Kinase Inhibitor 63 HSP# inhibitor 63 thymidylate synthase 63 MET VEGFR2 63 HCV protease 63 candidate deforolimus 63 apoptosis proteins 63 novel histone deacetylase 63 LPA1 63 Cyclooxygenase 63 small molecule thrombopoietin 63 4 PDE4 enzyme 63 Fc fusion protein 63 phosphatases 63 peptibody 63 Selective Inhibitor 62 Bruton tyrosine kinase 62 MTP inhibitor 62 investigational oral inhibitor 62 PTP 1B 62 small molecule Hedgehog 62 cyclin dependent kinases CDKs 62 hypoxia inducible factor 62 orally bioavailable 62 CDK inhibitor 62 JAK1 62 selective inverse agonist 62 reversible inhibitors 62 anionic backbone 62 PDE4 inhibitor 62 cyclin dependent kinases 62 virus HCV protease inhibitor 62 AN# topical anti 62 partial agonist 62 kinase inhibitor 62 Aurora Kinase 62 receptor partial agonist 62 anti amnesic 62 dasatinib Sprycel ® 62 p# mitogen activated 62 Accelerated Intelligent 62 poly ADP ribose polymerase 62 humanized monoclonal antibodies 62 antisense oligonucleotide 62 peptidic compound 62 non nucleoside HCV 62 Drug Discovery AIDD 62 opioid receptor antagonist 62 PEGylated Fab fragment 62 mitogen activated ERK kinase 61 PDGFR B 61 selective agonist 61 prostate secretory 61 tyrosine kinase receptor 61 Androgen Receptor 61 potently inhibits 61 NS3 protease 61 selectively inhibits 61 geldanamycin 61 pro apoptotic 61 proprietary polysaccharide 61 D aspartate NMDA receptor 61 mTOR mammalian target 61 5 HT4 agonist 61 oral isotype selective HDAC 61 kinesin spindle protein 61 CYC# 61 CDK cyclin dependent 61 potent inhibitor 61 sphingosine 1 61 BiTE ® 61 VEGF receptors 61 matrix metalloproteases 61 JAK2 Inhibitor 61 ATRA IV 61 xenograft models 61 Ii protein 61 protein tyrosine phosphatase 1B 61 Phosphodiesterase 61 NMDA N 61 methyl D aspartate 61 erlotinib Tarceva R 61 histone deacetylase 61 novel VDA molecule 61 targets HGF FGFR 61 proteasome inhibitors 61 glycogen synthase kinase 61 Factor VEGF 61 PDE# 61 Epothilone D 61 Thiarabine 61 thrombin receptor 61 receptor modulators 61 JAK#/JAK# 61 accumulate preferentially 61 VEGFR2 60 PI3K inhibitor 60 ® C1 esterase 60 Talabostat 60 Blinatumomab 60 FGFR 60 XL# anticancer compounds 60 Tumor necrosis factor 60 receptor tyrosine kinase inhibitor 60 5 HT2A inverse 60 ligand TRAIL 60 imatinib Gleevec ® 60 Pruvel TM 60 acetylcholinesterase AChE 60 humanized monoclonal antibody 60 BRAF kinase 60 nilotinib Tasigna ® 60 non thiazolidinedione TZD 60 prescribed proton pump 60 potent topoisomerase II 60 potent inhibition 60 LymphoStat B belimumab 60 DNA intercalator 60 Akt activation 60 5 HT4 60 mitotic kinesin 60 radiation sensitizer 60 endothelin receptor 60 targeted antifolate 60 CRTH2 60 Angiotensin Converting Enzyme 60 aspartyl 60 novel orally administered 60 kinesin spindle protein KSP 60 Hsp# Inhibitor 60 phosphate S1P 60 methionine aminopeptidase 60 anti fibrotic 60 Aflibercept VEGF Trap 60 dipeptidyl peptidase IV 60 inhibitor COX 60 anti angiogenic agent 60 Flt3 60 rhIGFBP 3 60 kidney urologic 60 vascular disrupting agents 60 small molecule activators 60 chemokine receptor 60 5 HT6 60 selective serotonin 2C receptor 60 methyl CpG binding 60 histone deacetylase inhibitor 60 histone deacetylase HDAC inhibitor 60 glycoprotein GP IIb IIIa 60 Voreloxin 60 phosphoinositide 3 60 PRT# 60 TLR7 60 TLR9 agonist 60 Abl 60 cell adhesion molecule 60 sphingosine kinase 60 BAL# [001] 60 ABLYNX 60 Mg Uk 60 pathophysiological effects 60 inverse agonist 60 erlotinib Tarceva ® 60 KSP inhibitor 60 peptide CGRP 60 tyrosine kinase inhibitor TKI 60 humanized anti 60 selective modulator 60 dasatinib Sprycel 60 delta gamma agonist 60 antisense inhibitor 59 type glutamate receptor 59 cyclin dependent kinase 59 mineralocorticoid receptor 59 triggers apoptosis programmed 59 RON Notch 59 N acetylgalactosamine 6 59 SGLT 59 AKT inhibitor 59 RAF kinase 59 Oral Fingolimod 59 cyclooxygenase COX 59 oral Hsp# inhibitor 59 Glucagon Like Peptide 59 Presents Preclinical Data 59 ABL inhibitor 59 Factor VIIa 59 SGLT 2 59 5HT 59 metaglidasen 59 introduced NEUGENE 59 Civacir TM Hepatitis C 59 subtype selective NMDA receptor 59 small molecule glucokinase 59 TO AVOID PREGNANCY WHILE 59 TLR7 agonist 59 selective phosphodiesterase 59 Alfacell proprietary ribonuclease 59 Telik logo TELINTRA 59 R2 LOR 59 oral ghrelin agonist 59 γ secretase 59 Hsp# inhibition 59 naloxol derivative 59 Sphingomab 59 highly selective endothelin 59 Proc Am Soc 59 Aptamer 59 MET RET 59 Orally administered 59 Potassium Chloride Sodium Ascorbate 59 novel peptide 59 protein kinase inhibitor 59 phosphatidylinositol 3 59 includes investigational compounds 59 HGS ETR1 mapatumumab 59 immunomodulating 59 Targeting microRNAs 59 orally dosed 59 Hedgehog signaling pathway 59 peripherally restricted 59 CGRP 59 oral Janus kinase 59 immunostimulatory 59 mGluR2 positive 59 HDAC inhibitor 59 PKC# 59 immune modulator 59 PI3K/Akt pathway inhibitor 59 mGluR5 negative 59 Enzastaurin 59 nucleoside analog 59 IMiDs ® 59 epothilones 59 Hsp# inhibitors 59 Polymerase Inhibitor 59 humanized antibody 59 regulated kinase 59 soluble epoxide hydrolase 59 GVAX ® 59 targetters 59 proteasome inhibitor 59 active AKT inhibitor 59 Oral NKTR 59 dependent RNA polymerase 59 #HT# 59 Locked Nucleic Acid LNA 59 5 HT1A 59 PRN FDA Approves 59 long acting muscarinic 59 % pramoxine HCl 59 Receptor Agonist 59 antiproliferative activity 59 agent VDA 59 Angiotensin 59 targeted alpha folate 59 Randomized Phase 59 TKB# 58 sulfonylhydrazine class 58 C5aR 58 Locked Nucleic Acid 58 mTOR inhibitor 58 demethylating agent 58 c MET 58 Novel Oral 58 anti proliferative 58 cyclooxygenase 2 58 PATENT FOR 58 oral nucleoside analogue 58 M1 muscarinic 58 Investigational Oral 58 #beta HSD1 58 intercellular adhesion molecule 58 potently inhibit 58 Elvitegravir 58 investigational pan BCR 58 mda 7 58 lysophosphatidic acid LPA 58 humanized therapeutic 58 monocyte chemotactic protein 58 interleukin IL 58 fosbretabulin 58 E3 ligase 58 product candidate Lpathomab 58 muscarinic 58 antiangiogenesis therapies 58 neuronal nicotinic receptor NNR 58 Phase 2b Clinical Trial 58 BLyS specific 58 Protein Kinase C 58 generation nucleoside analog 58 PEGylated anti 58 JAK2 inhibitor 58 immunoregulatory 58 Histone Deacetylase 58 small molecule agonists 58 DG# compounds targeting 58 agonism 58 VentiRx Pharmaceuticals 58 vinorelbine tartrate 58 brand ciclesonide HFA 58 R Saizen R 58 RONDEL TM 58 interferon beta 1a infertility 58 histone deacetylase HDAC 58 antiapoptotic 58 MKC# MT 58 calcitonin gene related 58 ERK1 2 58 Staphylococcus aureus Immune Globulin 58 actinin 58 R roscovitine CDK cyclin 58 interferon alpha IFN 58 hypoxia activated prodrug 58 VEGF receptor 58 Recombinant Human 58 Vidofludimus 58 tyrosine kinase 58 dual orexin receptor 58 JZP 58 Serdaxin ® 58 Amgen discovers develops 58 MEK ERK 58 HuCAL PLATINUM ® CysDisplay 58 pralatrexate injection folate analogue 58 R roscovitine 58 Exelixis compounds 58 VEGF inhibitors 58 forodesine purine nucleoside phosphorylase 58 Chemokine Receptor 58 PI3K/Akt pathway 58 Receptor Antagonist 58 sodium glucose transporter 58 platform HDL Mimetic 58 upregulation 58 Hsp# chaperone system 58 extracellular signal 58 non porcine pancreatic 58 2 inhibitor CYT# 58 vascular disrupting agent 58 eotaxin 58 2 methoxyestradiol 58 CCR2 58 THR beta agonist 58 phosphatidylinositol 58 MDRNA proprietary 58 demonstrated antitumor activity 58 nilotinib Tasigna 58 5 lipoxygenase activating 58 factor receptor FGFR 58 CCR9 antagonist 58 NMDA antagonist 58 polymer conjugate technology 58 oral antiviral 58 delta selective PI3K 58 small molecule inhibitors 58 including eniluracil ADH 58 mitogen activated protein kinase 58 Custirsen 58 CRAC channel 58 liposome encapsulated 58 FOLFOX6 chemotherapy regimen 58 Cardium Therapeutics TM 58 Fenretinide 58 mTOR kinase 58 cathepsin K inhibitor 58 vanilloid receptor 58 dopamine D2 58 antibody fragment 58 Preclinical studies suggest 58 Pruvel ™ 58 oral proteasome inhibitor 58 peripherally acting 57 Small Modular SMIP 57 selective adenosine 57 Pharmacokinetics PK 57 topical gel formulation 57 RAS MAPK pathway 57 refractory chronic lymphocytic 57 BCG refractory carcinoma 57 cyclooxygenase 57 novel orally bioavailable 57 Files IND 57 Tubulin 57 SENOMYX 57 Initiate Phase 57 selectively inhibit 57 small molecule defensin 57 CYP#A# substrate 57 product platforms AZX# 57 serine protease 57 chimeric monoclonal antibody 57 LHRH antagonists 57 Tesetaxel 57 5alpha reductase 57 dependent kinase inhibitor 57 Omacetaxine 57 receptor inhibiting monoclonal 57 CD4 monoclonal antibody 57 immunomodulator 57 fusion protein 57 angiotensin receptor blocker ARB 57 FLT3 57 somatostatin 57 Temsirolimus 57 Initiated Phase 57 Rigel R# 57 telomerase therapeutic 57 EGF receptor 57 Receives Orphan Drug Designation 57 IL 1β 57 selective inhibitors 57 class anticancer quinolone 57 targeted radiotherapeutic 57 Panzem R 57 androgen receptor AR 57 optical biosensors 57 anti leukemic 57 PI3 kinase 57 oncolytic virus therapies 57 sodium thiosulfate STS 57 alpha TNFa 57 NR2B selective 57 rusalatide acetate 57 enzyme inhibitor 57 endosomal release 57 humanized monoclonal 57 selective estrogen receptor modulator 57 AtuRNAi 57 Curaxin CBLC# 57 HMG CoA reductase inhibitors 57 Interferon gamma 57 essential thrombocythemia ET 57 Pathway Inhibitor 57 5 HT2A receptor 57 DFMO 57 CTLA 4 57 mediated inhibition 57 NS4A 57 MEK inhibitor 57 Vascular Disrupting Agent 57 Tofacitinib 57 tumor vascular disrupting 57 positive allosteric modulator 57 novel synthetic PEGylated 57 hypereosinophilic syndrome 57 ImmunoBody ® 57 Tumor Necrosis Factor 57 TNFα 57 LPA1 receptor 57 5 lipoxygenase 57 Squalamine 57 CB2 receptor selective 57 Provectus Pharmaceuticals specializes 57 MSCRAMM ® 57 taxane derivative 57 biased ligand 57 dimebon latrepirdine 57 AEG# 57 c MYC 57 receptor agonist 57 AKT1 57 nicotinic acetylcholine 57 colon carcinoma 57 Pertuzumab 57 HGS ETR2 57 T#I [002] 57 Preclinical studies 57 Angiotensin II 57 3 kinase PI3K 57 activin receptor type 57 JAK inhibitor 57 Luteinizing Hormone Releasing Hormone 57 Hypoxia Inducible Factor 57 monoclonal antibody IgG1 Mab 57 anti amnesic neuroprotective 57 delta opioid receptor 57 adecatumumab MT# 57 MEK inhibitors 57 Interferon alfa 57 Ceflatonin R 57 selective androgen receptor modulator 57 Anthrax Toxin 57 imatinib resistant 57 cytokine signaling 57 antibody MT# 57 Veronate R 57 HGS# 57 neurokinin 1 57 Pralatrexate 57 TNF α 57 RANK Ligand 57 M# rationally 57 receptor inhibitors 57 SAR# [002] 57 corticosteroid dexamethasone 57 mertansine 57 Interferon alpha 57 HIV integrase inhibitor 57 MET amplification 57 ADVANCE REVIEW 57 Vorinostat 57 PSN# [002] 57 IMPDH inhibitor 57 agonist compounds 57 cytotoxic T lymphocyte 57 amide hydrolase 57 inhibits protein synthesis 57 GMX# 57 sorafenib Nexavar 57 potent antitumor activity 57 PegIFN 57 adrenoceptor 57 HCV NS3 protease 57 anti angiogenic 57 MTP inhibitors 57 interleukin IL -# 57 neuropathic pain metabolic diseases 57 peptide peptide mimetic 57 coronary stent merged 57 induce apoptosis 57 receptor antagonists 57 molecule epidermal 57 skeletal sarcomere activators 57 neurotrophic 57 tyrosine kinase inhibitor 57 Gamma secretase 57 mediated apoptosis 57 antifibrotic 57 lintuzumab SGN 57 potent antiproliferative 57 S6 Kinase 57 Miraxion Amarin lead 57 protein tyrosine phosphatases 57 Gleevec resistant 57 pipeline ImmunoGen collaborators 57 Inhibitor 56 Nedd4 56 microRNA antagonists 56 AT1R 56 PI3K Akt 56 mu opioid receptor antagonist 56 Anticalin 56 including cyclosporine methotrexate 56 novel therapeutic antibodies 56 aurora kinase 56 proprietary PEGylation 56 Crofelemer budesonide foam 56 COPEGUS therapy 56 Initiates Phase II 56 receptor blocker 56 serine threonine 56 PDGFR 56 delivered RNAi therapeutic 56 topoisomerase 56 Angiocept 56 Secretase 56 WHILE THE COMPANY 56 cortisol receptor 56 Vaccine Adjuvant 56 potential vanilloid 56 Akt inhibitor 56 HCV protease inhibitor 56 Multiple Myeloma MM 56 generation purine nucleoside 56 anti CD3 56 endoplasmic reticulum stress 56 deacetylase 56 receptor inhibitor 56 M2 subunit 56 EARNINGS LOOK AHEAD 56 BiTE R 56 XOMA 3AB biodefense 56 selectively inhibited 56 BZL# 56 anti botulism antibody 56 peroxidase 56 Topoisomerase II 56 receptor CXCR4 56 IGF1R 56 dual PPAR peroxisome 56 SGLT2 56 Fleximer R 56 antagonist LAMA 56 Cobalamin TM mediated 56 Smac mimetic 56 acetylcholinesterase 56 oncolytic 56 somatostatin analogue 56 Xcytrin R 56 thromboxane A2 56 virus AAV 56 novel immunomodulatory 56 Aplidin 56 negative allosteric modulator 56 inhaled formulation 56 Initiates Phase 56 constitutively active 56 LX# LX# 56 methylnaltrexone bromide 56 murine model 56 MAPK pathway 56 selectively inhibit replication 56 immunomodulatory 56 TLR8 56 TRIOLEX HE# APOPTONE HE# 56 Zoraxel TM 56 hepatoprotective agent 56 inhibitor PPI 56 selective A2A adenosine receptor 56 ghrelin receptor 56 FUSILEV enhances 56 imatinib Gleevec 56 Receptor Antagonists 56 siRNA therapeutic 56 serologically active systemic lupus 56 ADCC enhanced 56 TGF ß 56 2M Transferrin Tfr 56 guanylate cyclase type 56 Î ² 56 Perifosine KRX 56 dipeptidyl peptidase 4 56 novel nucleoside analog 56 NFκB 56 abnormal p# 56 PDE4 modulators 56 S1P 56 humanized interleukin 6 56 small molecule VR1 56 ErbB 56 staphylococcal vaccine 56 Suppository Hydrocortisone Acetate Rectal 56 Long acting beta2 56 cathepsins 56 phosphorylates 56 inhibitor VX 56 world safest multivalent 56 Adenoviral 56 factor Xa 56 antitumor 56 compound perifosine 56 Aurora kinase inhibitor 56 hyperphosphorylation 56 EGFR tyrosine kinase inhibitor 56 constitutively activated 56 Pentad TM 56 antisense inhibitors 56 dihydrofolate reductase 56 FlipShare keeps 56 receptor tyrosine kinase 56 Systemic Delivery 56 Angiolix R 56 TMC# [002] 56 generation camptothecin analogue 56 aurora kinase inhibitor 56 orthotopic model 56 2 Microglobulin beta 56 Suppl. 56 Angiotensin converting enzyme 56 attach auristatin 56 estrogen receptor beta 56 LY# [002] 56 INDIVIDUALLY AND 56 LymphoStat B TM 56 E2F 56 BMS # 56 Intravenous Human 56 ENL recurrence 56 beta3 56 mGluR2 NAM 56 AND UNKNOWN COULD CAUSE 56 TELINTRA R 56 Endothelin 56 systemic lupus erythematosus rheumatoid 56 Treatment Naïve 56 NK1 56 acetonide FA 56 alpha#beta# integrin 56 6 sulfatase 56 secretory phospholipase A2 56 class mGluR5 inhibitor 56 live Lm vaccines 56 peroxisome proliferator activated 56 EnteroMedics proprietary neuroblocking technology 56 mediate RNAi 56 VE cadherin 56 transient receptor 56 Quinamed R 56 dependent cellular cytotoxicity 56 fatty acid amide hydrolase 56 motexafin gadolinium Injection 56 Atripla combines 55 next generation URAT1 55 NASDAQ MNKD focuses 55 ATL# [002] 55 oral picoplatin 55 IGF 1R 55 HDAC 55 thrombopoietin 55 Dasatinib 55 memantine HCl 55 Dapagliflozin 55 Maxy G# 55 SHOWTIME ON DEMAND 55 investigational oral 55 Prodarsan R 55 receptor agonists 55 GAD# 55 cladribine Cladribine Tablets 55 UltiMAb TM 55 E#F# 55 Cytochrome P# 55 NDTV HINDU # 55 Vidaza ® 55 protein receptors lectins 55 CysDisplay R 55 TNF alpha selectively neutralizing 55 intranasal vaccines derived 55 epothilone 55 CD# monoclonal antibody 55 chemokine 55 PARP1 55 Granulocyte Colony Stimulating Factor 55 ® SHOWTIME WOMEN 55 Atridox R Atrisorb 55 Survivin 55 ,#,# [002] 55 hypoxia selective 55 5 HT1A receptor 55 HINDU # 55 immune modulating 55 Imatinib mesylate 55 Nasdaq XTLB 55 beta amyloid peptide 55 6R BH4 tetrahydrobiopterin naturally 55 includes TOLAMBA TM 55 NKG2D 55 HuMax CD#b 55 p# alpha [001] 55 Aeolus Pharmaceuticals Announces 55 Pivotal Phase 55 glucagon receptor 55 arginine vasopressin AVP 55 Commences Phase 55 * olmesartan medoxomil 55 potently inhibited 55 2A receptor agonist 55 JAK3 inhibitor 55 subtype selective 55 Myeloid 55 FasL 55 nucleoside analogues 55 systemically administered 55 Archexin 55 gemcitabine Gemzar 55 Namenda Memantine HCl 55 sarcoma melanoma 55 tubulin binding 55 inhibit oxidative stress 55 anti CD# antibody 55 HuMax 55 novel emulsion formulation 55 PI3K/mTOR 55 TRANSDUR ™ 55 flavopiridol 55 binding protein IGFBP 55 Initiates Enrollment 55 USP Tablets MOVIPREP ® 55 mTOR inhibitors 55 Akt pathway associated 55 Bortezomib 55 PPARγ 55 Completes Patient Enrollment 55 angiogenesis inhibitor 55 Valproic acid 55 metabotropic glutamate receptor 55 MKC# 55 KL4 surfactant 55 Hsp# inhibitor 55 DiLA2 55 neuroprotective properties 55 Enkephalin 55 ALSO CALLED 55 Tyrima 55 nicotinic 55 Akt phosphorylation 55 soluble tumor necrosis 55 Ziprasidone 55 non nucleoside 55 By PETER LARSEN 55 CTAP# Capsules 55 evaluating tivozanib 55 Vascular Endothelial Growth 55 Inhibitors 55 TGF Beta 55 antiangiogenic agent 55 insulin sensitizer 55 investigational monoclonal antibody 55 Deforolimus 55 antisense drug 55 Zalypsis 55 anti androgen 55 recurrent metastatic ovarian cancer 55 protein CETP 55 NF kappaB activation 55 Submits NDA 55 tumor activated prodrug 55 targeted diseased tissues 55 software rapidly identif 55 TGF beta1 55 APR Labtec 55 immune stimulatory 55 potent anticancer 55 Luramist TM 55 dihydrochloride Tablets 55 pertuzumab 55 proven DuraSite ® 55 enkephalin 55 oncogenic signaling 55 selectively inhibiting 55 metabolic disorders Saizen R 55 products MKC# PP 55 anticancer therapeutics 55 novel proprietary KL4 55 Beta catenin pathway 55 DURECT proprietary 55 catenin 55 p# MAPK 55 alkylating agent 55 Y2 receptor 55 NASH Huntington 55 oxidative stress inducer 55 antiproliferative 55 HIF 1alpha 55 CORT # 55 prostaglandin E2 PGE2 55 Avanafil 55 Puls Biznesu pp. 55 proprietary BiTE ® 55 cytotoxin 55 antimetastatic activity 55 androgen receptor antagonist 55 muscarinic antagonist 55 novel RNAi therapeutics 55 Nventa proprietary CoVal 55 Enterobacter spp 55 receptor modulator 55 retinoic acid receptor 55 Spiegelmer 55 catalytic antioxidant compounds 55 novel orally inhaled 55 input XmlResolver Evidence 55 nucleotide analog 55 antibody MAb 55 modified glutathione analog 55 antiangiogenic 55 Symbioscience WISDOM PANEL 55 Raf kinase 55 ® bortezomib 55 METOZOLV ™ ODT metoclopramide 55 EP1 receptor 55 VERANTWORTLICH 55 insulin sensitizing 55 Leukotriene 55 NicVAX TM 55 brain penetrant 55 MAP kinase 55 immunotoxin 55 pharmacological chaperone 55 vivo validation 55 USP Tablets PEPCID 55 delipidation 55 Denufosol 55 recombinant PSMA vaccine 55 Nasdaq MNKD focuses 55 Declare Monthly Distributions 55 Agonist MABA program 55 comprise Alnylam RNAi 55 Begins Dosing 55 SMaRT ™ 55 NYSE Amex YMI 55 aldehyde dehydrogenase ALDH2 deficiency 55 Lipid Polymer Micelle LPM 55 OR THE APPLICABLE 55 Shrink OTCBB INKN 55 angiotensin analog 55 lipopeptide 55 III EGFRvIII 55 Degarelix 55 Nasdaq AEGR 55 drug zotarolimus 55 UCP2 55 HCl PEPCID ® famotidine 55 TNFalpha 55 Fovea Pharmaceuticals subsidiary 55 Affilin ® 55 PacketCable TM OpenCable TM 55 drug conjugate 55 N methyl 55 adenosine receptor 55 NFkB 55 glutamyl 55 nicotinic acetylcholine receptor 55 recombinant subunit vaccine 55 ARE READY TO 55 paclitaxel Taxol 55 AVAX AC Vaccine 55 Emergent marketed 54 immunomodulatory effects 54 Inhibits 54 TRANSDUR ® 54 vaccines oncolytic virus 54 inhibitory receptor 54 adhesion molecule 54 CHEMSAS R 54 monocytogenes Listeria vaccines 54 specific lectin receptors 54 mecamylamine 54 novel antimitotic agent 54 glycosyltransferase 54 synthetic cannabinoid compounds 54 alagebrium 54 Illusionist Toy Story 54 Micromet proprietary BiTE 54 R SHOWTIME FAMILYZONE 54 factor G CSF 54 FULL IMPACT